TOP 10 Controversies, Side-effects of ‘Sputnik V’ Russian Covid-19 Vaccine

[welcomewiki]

‘Sputnik V’: How Does Russian Covid-19 Vaccine Work? Why it is Under Question? FAQs Answered

At a time when a number of countries are working to find out vaccine for the deadly coronavirus, Russian President Vladimir Putin on Tuesday announced that his country has developed the world’s first vaccine against COVID-19 that works quite effectively. As per his claims, the vaccine forms a stable immunity against the disease. Also Read - ‘Sputnik V’: Russia Says it Has Received Orders From 20 Countries For 1 Billion Doses of Vaccine

“A vaccine against coronavirus has been registered for the first time in the world this morning,” Putin said during a meeting with members of his government. Also Read - Fake News: The Girl Receiving Covid-19 Vaccine in This Viral Video is Not Vladimir Putin's Daughter!

However, his claim has come amid concerns raised by experts about the speed of Russia’s work, suggesting that researchers might be cutting corners. Also Read - Russia First to Register Coronavirus Vaccine; Putin's Daughter Inoculated

Amid fears that safety could have been compromised, the World Health Organization (WHO) urged Russia to follow international guidelines for producing a vaccine against COVID-19. Moreover, the Russian vaccine is not among the WHO’s list of six vaccines that have reached phase three clinical trials, which involve more widespread testing in humans.

How Does Russian Covid-19 Vaccine Work?

• As per reports, the vaccine developed by Russia is based on the DNA of a SARS-CoV-2 type adenovirus, a common cold virus.
  
• To make it effective, the vaccine uses the weakened virus to deliver small parts of a pathogen and stimulate an immune response.
• Talking in details, Alexander Gintsburg, director of the Gamaleya National Research Centre, told news agencies that the coronavirus particles in the vaccine cannot harm the person’s health.
• He said some people have fever when they get vaccinated; otherwise there is no such side effect of the vaccine.

Why the Russian Covid-19 vaccine under question?

• According to experts, the Sputnik V has not yet undergone phase 3 trials.
  
• Russia said it will undergo human trial on Wednesday.
• Some other experts criticise that Russia has skipped certain steps that are needed in vaccine development.

Fresh allegations have come up that the Russian government pressurised the scientists to speed up development of the vaccine which may result in deadly consequences.

While making the announcement, Putin said one of his daughters had tested a Russian COVID-19 vaccine on herself and that she is feeling well. He said that the first Russian COVID-19 vaccine forms stable cell and antibody immunity.

[welcomewiki]

New Delhi: Hours after Russia announced that the country has developed first vaccine that works quite effectively for coronavirus, Moscow on Tuesday said it has received orders from 20 countries for one billion of doses of the vaccine. Known as ‘Sputnik V’, the vaccine forms a stable immunity against COVID-19. Also Read - ‘Sputnik V’: How Does Russian Covid-19 Vaccine Work? Why it is Under Question? FAQs Answered
Kirill Dmitriyev, who heads the Russian Direct Investment Fund that finances the vaccine project, said the Phase 3 trials of the vaccine would start on Wednesday and the industrial production is expected to begin from September. Also Read - Health of ex-President Pranab Mukherjee, Operated For Brain Clot, Has Worsened: Army's R&R Hospital

Giving further details about the vaccine production, he said that Russia along with other foreign countries is ready to manufacture 500 million doses of vaccine per year in five countries. Also Read - Unlock 3.0 in Gurugram: Worship in Religious Places Allowed From Tomorrow | Read Here
The development comes after Russian President Vladimir Putin announced that his country has developed first vaccine that works quite effectively against COVID-19.

Putin said that one of his daughters took part in the experiment and she was vaccinated against the coronavirus.

“After the first vaccination, she had a body temperature of 38 degrees Celsius, while the following day it was slightly over 37 degrees Celsius, that’s it. After the second injection, the second vaccination, her temperature also rose a little, and then everything cleared up, she feels good and the [antibody] titers are high, Putin said.

Health Minister Mikhail Murashko has said that the first Russian vaccine against the coronavirus will begin to be produced at two sites – the Gamaleya Research Institute and the company Binnopharm.

As per updates, the clinical trials of the vaccine started on June 18 and included 38 volunteers. All of the participants developed immunity. The first group was discharged on July 15, the second group on July 20.

[welcomewiki]

Sputnik V: Russia's COVID Vaccine Passes Early Trial Test, Produces Antibody Response, Says Lancet Study



New Delhi: Claimed as world’s first coronavirus vaccine, Russia’s new COVID vaccine has passed early trial test and the patients involved in early tests developed antibodies with no serious adverse effects, a research article published in The Lancet said. Also Read - Defence Minister Rajnath Singh to Visit Russia Tomorrow For SCO Event Amid Border Flare-up With China

The development comes as Russia had last month claimed that it has developed word’s first corona vaccine with the name ‘Sputnik V’ after the Soviet-era satellite that was the first launched into space in 1957. Also Read - Doctors Pull 4-Feet Snake Out of Woman's Mouth in Russia, Horrifying Video Emerges | Watch

The Russian researchers in The Lancet reported that two small trials, each involving 38 healthy adults aged between 18 and 60, were given a two-part immunisation. As per the report, the participants were monitored over 42 days and all developed antibodies within the first three weeks. Also Read - Russia Begins Trials of Second Coronavirus Vaccine, Likely to Approve by Late September | Read Here

According the report in The Lancet, over 76 participants of these trials would be monitored up to 180 days and more rigorous phase 3 clinical trial was planned with the involvement of 40,000 volunteers from different age and risk groups.

“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection The Lancet said.

Earlier, Russia had said that it is planning to produce 6 million doses of coronavirus vaccine per month. The RIA news agency cited Russian Industry Minister Denis Manturov as saying that Russia is planning to produce between 1.5 million and 2 million doses per month of its potential coronavirus vaccine by the year end.

In another development, Russia had said it is looking for a partnership with India for producing COVID-19 vaccine Sputnik V. Russian President Vladimir Putin had announced that his country has developed the world’s first vaccine against COVID-19, which works quite effectively and forms a stable immunity against the disease.

The Sputnik V vaccine consists of two shots that use different versions of adenoviruses — virus types, some of which cause the common cold — that the manufacturers have engineered to carry the gene for the surface protein of SARS-CoV-2 that causes COVID-19.